Mario Tiribelli

61PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMedical mycologyImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jun 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

|May 28, 2026
Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front-line hypomethylating agents and venetoclax: A retrospective Italian study.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Mar 25, 2026
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Paola Guglielmelli, Massimo Breccia, Francesco Mendicino

|Feb 21, 2026
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Francesca Palandri, Venediktos Kapetanakis, Balázs Dobi

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

Pageof 11

Frequent Collaborators

33 joint publications

Massimo Breccia

27 joint publications

Elisabetta Abruzzese

27 joint publications

Massimiliano Bonifacio

20 joint publications

Francesca Palandri